Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Developments in liposomal gene delivery systems

N S Templeton

    Expert Opinion on Biological Therapy
    |December 1, 2001
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Identification and removal of colanic acid from plasmid DNA preparations: implications for gene therapy.

    Gene therapy·2010
    Same author

    A combinatorial approach for targeted delivery using small molecules and reversible masking to bypass nonspecific uptake in vivo.

    Gene therapy·2010
    Same author

    Intravenous delivery of liposome-mediated nonviral DNA is less toxic than intraperitoneal delivery in mice.

    World journal of surgery·2005
    Same author

    Liposomal enhancement of the antitumor activity of conditionally replication-competent adenoviral plasmids.

    Molecular therapy : the journal of the American Society of Gene Therapy·2004
    Same author

    Modeling human breast cancer metastasis in mice: maspin as a paradigm.

    Histology and histopathology·2003
    Same author

    Conformational regulation of the fibronectin binding and alpha 3beta 1 integrin-mediated adhesive activities of thrombospondin-1.

    The Journal of biological chemistry·2001
    Same journal

    TNF inhibitors for the long-term management of juvenile idiopathic arthritis associated uveitis: real-life data from the ITHACA cohort.

    Expert opinion on biological therapy·2026
    Same journal

    Type 2 inflammation and biologics: a twenty-year journey.

    Expert opinion on biological therapy·2026
    Same journal

    Current outlook on the use of biological agents to improve outcomes in adult secondary hemophagocytic lymphohistiocytosis.

    Expert opinion on biological therapy·2026
    Same journal

    Addressing challenges in disease management of childhood-onset systemic lupus erythematosus: the role of biologics, with primary focus on rituximab and belimumab.

    Expert opinion on biological therapy·2026
    Same journal

    Biological drugs for the treatment of children with atopic dermatitis.

    Expert opinion on biological therapy·2026
    Same journal

    Optimizing biologic therapy in psoriasis: dose adjustment, treatment duration, and tapering-an expert perspective.

    Expert opinion on biological therapy·2026
    See all related articles